|
Getting your Trinity Audio player ready...
|
The University of Rochester Medicine Clinical & Translational Science Institute has landed more than $29 million in new federal funding. The center has received over $157 million in grants for translational research across two decades.
“For 20 years, CTSI has served a critical infrastructure role for translational science and research at URochester Medicine,” says David Linehan M.D., CEO of the University of Rochester Medical Center and dean of the School of Medicine and Dentistry. “The CTSI team supports our academic and clinical missions by accelerating lab discoveries to bedside implementation and promoting team science. They will continue to play a pivotal role in achieving our research mission.”
The latest influx of research dollars came from the National Institutes of Health’s National Center for Advancing Translational Sciences and the Clinical and Translational Science Awards Program. URochester is one of more than 60 institutions nationwide that receive CTSA program funding.
The new grants center on translational science—removing research barriers by innovating through artificial intelligence and machine learning and accelerating high-quality clinical trials, officials say. The second area of focus is “improving health for all,” moving research from bench to bedside, addressing local and national health priorities, and expanding access to cutting-edge clinical trials.
“We are showing the research community how translational science can reduce barriers to make research more meaningful for all,” says Karen Wilson M.D., co-director of CTSI. “Translational science can make a real difference in the lives of those receiving treatment because it makes health care research faster, less expensive, and more impactful.”
Martin Zand M.D., co-director of the center, says the grants will also help fund training and mentorship of up-and-coming scholars. In addition, it will support innovative research projects and offer training and education programs to improve URochester’s clinical trials workforce.
CTSI first received funding in 2006. Since then, it has been working with research teams, community members and nonprofits. The new grant is expected to bolster the university’s ties to rural communities. CTSI is working closely with Common Ground Health and the Center for Community Health and Prevention for these community engagement activities, officials say.
“The University of Rochester is a national leader in research that improves human health,” President Sarah Mangelsdorf says. “This funding will ensure our researchers have the tools they need to connect, learn, and get what they need to advance their knowledge and practice, develop cutting-edge treatments and therapies, and bring hope to people receiving care in the Rochester region and beyond.”
Sen. Chuck Schumer and Rep. Joe Morelle both lauded URochester’s research and innovation.
The grant continues through 2032.
Smriti Jacob is Rochester Beacon managing editor.
The Beacon welcomes comments and letters from readers who adhere to our comment policy including use of their full, real name. See “Leave a Reply” below to discuss on this post. Comments of a general nature may be submitted to the Letters page by emailing [email protected].